BSX vs OUSTZ · P/E 20, rev $10.65B vs rev $111.1M
Boston Scientific Corp (BSX) versus Ouster, Inc. Warrants (OUSTZ) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Ouster, Inc. Warrants (OUSTZ) is a electronic components company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported OUSTZ revenue for 2024-12-31 was $111.1M. Net income was -$97.0M. Revenue was up 33.4% from 2023-12-31 to 2024-12-31. OUSTZ currently screens at market cap $0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. OUSTZ currently screens at market cap $0.
Not investment advice. Open the BSX and OUSTZ stock pages for the full models.
Not investment advice.